Alternatives to Cloudbyz Safety and Pharmacovigilance (PV)

H1 Universe is an innovative platform that leverages artificial intelligence to enhance the management of healthcare data, offering users access to the most extensive global database of healthcare providers (HCPs). By merging information from various sources, such as public, private, and proprietary databases, H1 Universe provides valuable insights that are crucial for clinical trials, medical affairs, and commercialization efforts. This powerful tool enables healthcare teams to pinpoint essential stakeholders, refine clinical research processes, and make informed decisions swiftly, ultimately boosting overall efficiency within the healthcare landscape. Furthermore, the platform not only aids in real-time decision-making but also fosters collaboration among healthcare professionals, paving the way for improved patient outcomes.

Numerous organizations globally rely on IQVIA to accelerate the drug development process, guarantee the safety and quality of products, enhance commercial efficacy, deliver appropriate treatments to patients, and ultimately promote improved health outcomes by facilitating access to and delivery of healthcare. Transform your approach to clinical development by seamlessly integrating data, technology, and analytics to streamline your trials. The outcome? Quicker decision-making and minimized risks, enabling you to provide transformative therapies at a faster pace. With its expertise rooted in data, sophisticated analytics, and deep industry knowledge, IQVIA offers tailored capabilities to clients throughout the healthcare landscape. Stay informed by exploring the latest insights and updates from IQVIA's data scientists, healthcare professionals, researchers, and other industry experts on crucial topics that resonate with your interests. From emerging industry developments to practical applications of our capabilities, a wealth of information awaits you here. Engaging with this content also empowers you to stay ahead in a rapidly evolving healthcare environment.

Tepsivo offers innovative pharmacovigilance software solutions that enhance the efficiency of drug safety processes through automation and intelligent templates, leading to a significant decrease in administrative workload and related expenses. The Tepsivo Platform is an all-encompassing, cloud-based system that empowers users to oversee all aspects of pharmacovigilance from a single, unified interface. Its notable features encompass a Quality Management System, oversight by a Local Contact Person for Pharmacovigilance (LCPPV), efficient safety reporting and follow-up mechanisms, PSUR tracking, management of signal detection, automated audit trails, compliance monitoring, tools for adverse event intake, literature surveillance, tracking of risk management systems, solutions for managing PSMF, automated reconciliation with partners, and CAPA management. By integrating these modules, the platform guarantees complete transparency, full compliance with regulations, preparedness for inspections, high-quality outputs, rapid processing times, elimination of administrative overhead, and reduced costs. With Tepsivo's solutions, organizations can enhance their pharmacovigilance capabilities while ensuring that they meet industry standards efficiently and effectively.

Clinevo's electronic Trial Master File (eTMF) is a user-friendly digital solution for the organization and storage of documents, images, and various digital assets related to clinical trials. This eTMF incorporates an integrated DIA reference model and complies with regulatory standards. Additionally, Clinevo offers the MICC Intake, a web-based platform designed for Medical Information Call Centers (MICC) and Pharmacovigilance (PV) professionals to efficiently log, track, and monitor Product Quality Complaints (PQCs), Medical Inquiries (MIs), and Adverse Events (AEs). Furthermore, Clinevo Safety serves as a comprehensive cloud-based system that ensures ease of use and regulatory compliance throughout the entire Pharmacovigilance process, encompassing PV Intake, Case Processing, Regulatory Submissions/AS2 Gateway, Analytics, and Safety Signals, all within a single platform. Lastly, the Clinevo Website Intake tool can seamlessly integrate with Sponsor or CRO websites, offering consumers and reporters an intuitive web interface for easy access and reporting. This innovative suite of tools enhances the efficiency and effectiveness of clinical trial management and safety reporting.

CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.

NewTn's SAFETY is a cutting-edge cloud platform for pharmacovigilance that aims to streamline safety processes and ease compliance for pharmaceutical companies, emerging startups, and contract research organizations. This solution presents a wide array of features, such as scalable cloud infrastructure for enhanced data storage and processing, the ability to reuse data to avoid repetitive entries, real-time alerts and monitoring to swiftly detect adverse reactions, and strong reporting capabilities that aid in creating DSUR and PBRER reports. Specific use cases demonstrate its value in building pharmaceutical safety databases for new companies, offering budget-friendly safety solutions for cost-conscious CROs, improving regulatory adherence for small and medium-sized pharmaceutical firms, and providing thorough safety data analysis and reporting. The platform is distinguished by its user-friendly interface and experience, along with its specialized support for DSUR and PBRER reporting, making it a versatile and customized solution for various stakeholders in the pharmaceutical industry. Moreover, NewTn's SAFETY ensures that all users can effectively navigate the complexities of safety management with confidence and ease.

Sentria is a cutting-edge platform that utilizes artificial intelligence to manage adverse event cases and conduct post-marketing surveillance. This software solution is user-friendly, highly customizable, and automated, ensuring it meets industry regulations to improve the efficiency, speed, and accuracy of adverse event handling. It supports pharmacovigilance compliance with international ICH guidelines while adhering to local regulatory requirements for the assessment of adverse events. By providing an easy-to-use interface enhanced with pharmacovigilance automation, Sentria minimizes reporting errors through smart alerts and simplifies report processing by employing international coding standards such as MedDRA and ATC/WHO. The platform enhances analytical capabilities through the use of semantic artificial intelligence tailored for pharmacovigilance needs. Notably, Sentria offers features like secure access controlled by user credentials, comprehensive auditable logs to ensure compliance, and a secure encrypted cloud environment for data protection. These functionalities collectively empower organizations to manage adverse events more effectively, contributing to better patient safety outcomes.

PvEdge is a state-of-the-art cloud-based pharmacovigilance software crafted to deliver comprehensive and compliant safety solutions for pharmaceuticals, medical devices, vaccines, and their combinations. It features an all-encompassing safety database that streamlines the management of pharmacovigilance intake, case processing, submissions, AI-driven analytics, and safety signal detection within a single user-friendly interface. This platform is designed to meet both current and forthcoming regulatory standards, including 21 CFR Part 11, ANNEX 11, GxP, and GDPR, thus ensuring worldwide compliance. By harnessing the power of advanced automation through AI and machine learning technologies, PvEdge significantly boosts the efficiency of drug safety database management. Notable functionalities encompass automated literature review, expedited ICSR submissions, intelligent triage processes, automated signal detection, and streamlined document automation. Additionally, the system incorporates a controlled document management feature that facilitates the creation, oversight, and dissemination of essential pharmacovigilance documentation, alongside a risk-based enterprise quality management framework aimed at establishing robust quality control processes and maintaining meticulous training records. Through these diverse capabilities, PvEdge stands out as an invaluable tool for organizations committed to upholding the highest standards in drug safety.

Veeva Vault Safety is an advanced system designed for the management of individual case safety reports, facilitating the collection, processing, and reporting of adverse events related to both clinical trials and marketed products. This comprehensive platform allows sponsors and contract research organizations (CROs) to handle both global and local adverse events for various categories, including drugs, biologics, vaccines, devices, and combination products. Its integrated gateway connections and established reporting protocols enhance the efficiency of submitting cases to regulatory authorities and sharing information with partners. Additionally, the centralized management of coding dictionaries automates updates for MedDRA, WHODrug, and EDQM on a semi-annual basis. By consolidating pharmacovigilance processes within a single cloud environment, Vault Safety promotes proactive measures in ensuring patient safety. The system also utilizes real-time reports and dashboards, coupled with seamless collaboration, to enhance visibility and ensure compliance regarding adverse event reporting. Ultimately, this innovative solution transforms the approach to safety management in the pharmaceutical industry, fostering a more efficient and effective response to patient safety concerns.

AccelSafety is an all-encompassing pharmacovigilance solution crafted by Techsol Life Sciences, centered around the Oracle Argus Safety application, designed to streamline the unified gathering, medical evaluation, and regulatory reporting of safety surveillance data for both clinical and post-marketing purposes. This fully managed cloud-based platform empowers emerging biopharma companies, device manufacturers, and service providers to effectively handle safety data while ensuring their business decisions align with global compliance standards. Among its primary advantages are expedited Argus Safety implementation, migration, and validation that reduce effort by 70%; secure transfer of existing safety data to the AccelSafety Cloud; and enhanced case processing efficiency through tailored configurations and built-in automation. Additionally, users benefit from extensive operational insights provided by advanced reporting tools, line listings, and analytics packages, as well as round-the-clock support from the Argus Safety Service Desk for user inquiries, incident resolutions, and change management needs. Overall, AccelSafety stands out as a pivotal tool for organizations looking to optimize their pharmacovigilance processes and uphold regulatory obligations effectively.

The IQVIA Vigilance Platform represents a holistic solution designed to streamline safety and pharmacovigilance tasks, enhancing speed, precision, and overall efficiency. Operating within a secure Software-as-a-Service (SaaS) environment and leveraging advanced proprietary technologies such as artificial intelligence, machine learning, and natural language processing, the Vigilance Platform provides valuable insights that enhance compliance, ensure product safety, and contribute significantly to the product development lifecycle. It comprehensively addresses every facet of pharmacovigilance, managing cases from initial patient reports through processing and submission to regulatory authorities, encompassing all types of cases. With its user-friendly interface, the IQVIA Vigilance Platform is accessible for affiliates, case processing teams, and those involved in signal detection. By adopting a transformative methodology in pharmacovigilance, it bolsters compliance, allowing organizations to concentrate on the rapid delivery of safer and more effective pharmaceuticals and medical devices. This innovative platform not only meets current industry needs but also anticipates future requirements in the evolving landscape of drug safety and efficacy.

TARA PV is an all-encompassing, online pharmacovigilance safety database specifically crafted to handle the processing, storage, analysis, and reporting of adverse events associated with pharmaceuticals, medical devices, and vaccines. Created by MedGenesis Ltd, a UK software development firm accredited with both ISO 9001 and ISO 27001, TARA PV boasts an interface that is user-friendly, straightforward, and fully adheres to regulations such as 21 CFR Part 11, GxP, ICH standards, and international pharmacovigilance data protection laws. As a cloud-based system, TARA PV eliminates the need for installation, allowing users to access it through any web browser, which facilitates swift implementation and seamless workflows for managing individual case assignments. Upon deployment, users receive comprehensive training, and continuous support is offered via an online ticketing system to address any issues that may arise. Prioritizing security, the platform is hosted with multiple redundancies and triple-layer backups to ensure data integrity. Additionally, TARA PV presents a variety of clear pricing options without any hidden fees, making it a transparent choice for organizations. This comprehensive solution is built to adapt as the regulatory landscape evolves, ensuring ongoing compliance and support for its users.

The Drug Safety Triager, developed by Clarivate, represents an advanced pharmacovigilance tool aimed at helping life sciences organizations adhere to regulatory standards. This system, which is validated for Good Practice (GxP) compliance and prepared for audits, enhances and organizes the workflow associated with literature reviews, allowing pharmacovigilance professionals to prioritize patient safety by streamlining these processes. Fully compliant with the reporting demands of major global safety regulatory bodies, including the FDA and EMA, the Drug Safety Triager includes a comprehensive validation package with every implementation. The validation documentation is carefully constructed to meet the stringent requirements set forth by the pharmaceutical sector and health authorities. Additionally, every piece of literature referenced is subjected to a meticulous review process that ensures all user actions are recorded, creating a permanent, immutable audit trail for accountability and transparency. This innovative approach not only improves efficiency but also reinforces the commitment to maintaining high standards in patient safety and regulatory compliance.

Clinevo Safety serves as a comprehensive, cloud-based pharmacovigilance and drug safety solution that is both user-friendly and compliant with regulatory standards. This all-encompassing platform incorporates various functions, including PV intake, case processing, regulatory submissions via an AS2 gateway, analytics, and safety signal detection. Leveraging a straightforward technology architecture, it allows for significant configuration options with minimal need for customizations, resulting in reduced total ownership costs and straightforward maintenance. Users benefit from alerts for cases approaching their deadlines, ensuring they remain compliant in a timely manner. The system features advanced automation and AI capabilities that enhance case processing efficiency, while its easily configurable dynamic workflows facilitate faster case management. Through sophisticated analytics, the platform provides users with impactful and actionable insights. As a web-based application, it can be accessed from any device, at any time, using common browsers such as Internet Explorer, Chrome, and Firefox, making it exceptionally convenient for users on the go. Furthermore, its design prioritizes usability, ensuring that all users can navigate the system with ease and confidence.

Ennov's Pharmacovigilance Suite serves as a comprehensive solution for the collection, management, assessment, and reporting of adverse events in both human and veterinary fields, all within a single database framework. It boasts sophisticated tools for signal detection and data analysis, reinforcing adherence to international regulatory standards. Notable features encompass streamlined case intake and triage processes, enhanced user interfaces for data entry, adaptable case input forms, and an extensive range of searchable vocabulary lists. The system accommodates various reporting formats, including both paper and electronic submissions, compatible with CIOMS guidelines, MedWatch 3500s, and ICH E2B standards (R2 and R3). In terms of signal detection and management, it offers extensive data querying options, robust analytical tools, and the ability to compute essential statistical measures such as PRR, ROR, and MGPS. Entirely web-based and user-friendly, the platform is built to meet the standards of 21 CFR Part 11, thereby guaranteeing the integrity and security of data. Moreover, its adaptability makes it suitable for organizations of all sizes, ensuring that users can efficiently navigate the complexities of pharmacovigilance.

Quanticate delivers extensive services in pharmacovigilance, which include the establishment and oversight of safety databases specific to pharmacovigilance. These safety databases act as the primary collection point for individual case safety reports gathered worldwide for a company's pharmaceutical products. Keeping these databases current with the latest regulatory guidelines and ensuring they are validated according to international standards and business requirements is crucial. Quanticate underscores the necessity of choosing the appropriate database by evaluating factors such as the costs associated with implementation and maintenance, the availability of hosting models (including internal infrastructure, third-party hosting, or vendor cloud solutions), previous experiences, and how well they integrate with existing systems. They warn that, despite many commercial databases claiming adherence to standards like ISO ICSR ICH-E2B, achieving genuine compliance necessitates meticulous configuration, validation, and ongoing management. Furthermore, ongoing support and updates are critical to maintain the integrity and reliability of these safety databases over time.

Orbit is a comprehensive platform geared towards improving patient safety by aiding biopharma companies of all sizes in expanding their safety operations across international markets. This platform provides cutting-edge solutions for global pharmacovigilance, safety management, and risk oversight, with the goal of enhancing overall quality, ensuring compliance, boosting productivity and efficiency, and offering significant oversight of processes that are often complex and compartmentalized. Among its essential features are risk management and minimization, which facilitate the monitoring of commitments within global risk management plans while also supporting the implementation of local risk mitigation measures; management of safety data exchange and pharmacovigilance agreements, which enables effective oversight of global collaborations; as well as signal and surveillance management, which encompasses everything from strategy planning to detection activities, signal evaluation, and ongoing tracking. Additionally, Orbit’s user-friendly interface ensures that teams can easily navigate the platform and utilize its features to their fullest potential.

Fusion is Axiom’s proprietary, cost-effective and easy-to-use eClinical solution. It is aimed at small to medium-sized device, pharma and biotech companies. Axiom's Fusion eClinical Suite allows you to add-on any Modules that meet your study needs. Are you running a small study? You can choose the base configuration with EDC and DM, as well as AE/SAE tracking. Are you looking for something more? To make managing your study easier, you can include powerful Modules like Inventory Tracking, RTSM, Safety Management. You can save time by electronically capturing your study data - even offline! Once you have an internet connection, your data will sync to your Fusion databases. Real-time records available for subject screening activities. Fusion Safety Database allows you to manage pharmacovigilance events.

Harnessing actionable insights from the leading AI-driven clinical analytics platform allows your teams to effectively manage risk and enhance performance throughout studies, systems, sites, and vendor relationships. The cutting-edge technology from Saama is specifically crafted to optimize workflows, automate labor-intensive tasks, and foster improved collaboration among various clinical functions such as operations, medical review, data management, biostatistics, and pharmacovigilance. Both sponsors and CROs depend on Saama's capabilities for data aggregation and AI solutions, which facilitate superior decision-making, minimize delays, and drastically reduce costs and timelines associated with drug development. By leveraging Saama's tools, you can accelerate the pace of clinical trial innovation. When your clinical data is centralized and continuously updated, it simplifies the lives of your ClinOps and medical review teams considerably. Furthermore, Data Managers, often undervalued, can shift their focus from repetitive tasks to the critical data points that truly drive project success, ensuring that their expertise is fully utilized in the process. This transformation not only enhances efficiency but also contributes to the overall quality of clinical outcomes.

The Thrana Safety Database is a cloud-centric system focused on pharmacovigilance and drug safety management. Crafted to prioritize user experience, this comprehensive solution effortlessly combines essential features like PV Intake, Case Processing, Regulatory Submissions via AS2 Gateways, Regulatory Reports, and Analytics, all conveniently available from a single, unified platform. This integration enhances efficiency and streamlines workflows for users across the industry.

Argus stands out as the premier and reliable solution for managing, analyzing, and reporting adverse event cases linked to both premarket and post-market drugs, biologics, vaccines, devices, and combination products. Enhance your case management capabilities with advanced features like integrated automation, optimized workflows, and touchless processing options that adapt to your needs. This mature solution ensures compliance with global drug, vaccine, and device regulations and standards, including E2B(R3), E2B(R2), eVAERS, eMDR, MIR, and IDMP, making it a dependable choice for organizations worldwide. With Argus Advanced Cloud, users gain access to Oracle Analytics, an AI-driven tool that not only reveals valuable insights but also enables quicker, more informed decision-making. As medicinal product safety teams navigate the challenges of increased caseloads, diverse signal detection data sources, and evolving regulations, they must do so with limited budgets and resources, making efficient solutions like Argus essential for their success. Ultimately, Argus helps organizations maintain safety and compliance in a complex landscape while optimizing operational efficiency.

SafetyEasy by EXTEDO is a robust software solution for managing pharmacovigilance and multivigilance, aimed at simplifying the handling of safety cases and vigilance information. It adheres to a wide range of drug safety regulations such as E2B(R3) and HL7 eMDR, while facilitating the necessary creation of regulatory documents including PSUR, PBRER, and DSUR. The software is equipped with features that optimize workflows through email alerts and online dashboards, allowing users to efficiently monitor project progress and adhere to submission timelines. Additionally, SafetyEasy features sophisticated tools like CasEasy AI, which leverages Natural Language Processing to streamline the automation of case creation, alongside a Business Intelligence module that offers an insightful 360° perspective on scientific data, thereby improving case evaluation and safety signal identification. This cloud-based platform is not only quick to deploy but also designed for ease of use, requiring very little training for effective operation. Furthermore, the integration of these advanced functionalities makes SafetyEasy an invaluable asset for organizations aiming to enhance their pharmacovigilance processes.

DF mSignal is a modular and scalable safety signal management system that enhances the efficiency of signal detection processes and risk management across pharmaceuticals and medical devices. It also includes cosmetics and nutraceuticals. The platform provides active and passive monitoring with real-time monitoring product-event combination, customizable clinical risk indicators, and an interactive interface with advanced analytics. It integrates seamlessly into MedDRA, WHO DD, clinicaltrial.gov and electronic data collection systems, providing a comprehensive safety solution for professionals. DF mSignal AI automates statistical scores to save time and ensure accuracy in signal detection. The system is designed to comply with all applicable regulations, including 21 CFR Part 11, data privacy and integrity controls, as well as GxPs. This ensures compliance and security.

Cloudbyz CTMS is a cloud-based trial management platform natively built on Salesforce Cloud. It is aimed at sponsors, clinical research organizations (CRO), and clinical sites for managing end-to-end clinical trial operations. Designed for clinical research, it expedites implementation and drives user adoption. Cloudbyz CTMS comes with an intuitive, straightforward design that allows for quick deployment. Boasting a rich set of features, Cloudbyz CTMS makes it easy for users to manage all aspects of clinical trials, including sites, enrolment, documents, events, milestones, site visit reports, finances, inventory, etc. The solution benefits are listed below- 1. Secure, reliable & scalable 2. Faster time to value 3. Monitor study progress & risks from planning to close-out 4. Seamless collaboration among sponsors, CROs & sites 5. Improved clinical team efficiency

Streamlined surveillance of diverse data sources, seamlessly integrated with a GVP IX compliant signal management platform, can revolutionize your safety data handling. The Evidex platform offers a ready-to-go, GVP-IX compliant signal management solution that simplifies your operations without the hassle of switching between various services. By modernizing your management processes, you can ensure they are audit-proof and efficient. This automation not only helps meet regulatory standards but also enhances the overall value generated for your organization. With automated signal detection, you can identify safety signals from established sources such as ICSR databases, the FDA's Adverse Event Reporting System (FAERS), VigiBase, and clinical trial data. Furthermore, you can incorporate additional data sources, including claims, electronic health records (EHR), and other unstructured information. By aggregating these diverse data pools, you can significantly improve signaling algorithms, streamline validations and assessments, and accelerate responses to pressing drug safety inquiries. Ultimately, this approach transforms how organizations manage and leverage safety data for better outcomes.

PubHive Navigator is an innovative software solution that utilizes artificial intelligence to enhance the efficiency of scientific literature and safety processes for life science organizations, regardless of their size. It provides a comprehensive suite of workflow solutions that encompass literature review, curation, annotation, collaboration, searching, reporting, citation management, and research oversight. The platform boasts AI-driven smart workspaces that facilitate centralized management of literature, collaborative writing for research projects, and effective team communication, along with integrations for document delivery and reuse rights, as well as pre-configured workflows tailored to various operational units. Furthermore, PubHive Navigator aims to streamline the complexities associated with enterprise-level scientific literature and safety information workflows, thereby offering a versatile tool for teams engaged in drug safety and pharmacovigilance, medical affairs, clinical affairs, and research and development. This adaptability allows organizations to optimize their research processes and enhance productivity across their teams.

DrugCard is an advanced data intelligence platform that leverages artificial intelligence to enhance the efficiency of pharmacovigilance by automating the screening of local literature. Supporting over 100 languages, it actively monitors more than 1,000 medical journals in over 55 countries, ensuring thorough, ongoing, and transparent oversight. By automating repetitive tasks, DrugCard allows Contract Research Organizations (CROs) to handle a greater number of pharmacovigilance projects while improving the quality of their screening results. Additionally, Marketing Authorization Holders (MAHs) can perform in-house literature screening more efficiently, and freelancers can reclaim as much as 70% of their time, which can then be directed towards more valuable activities. The platform is built to be adaptable to new markets, affordable, and in line with regulatory standards, thus offering a well-rounded solution for drug safety departments. Its innovative features not only optimize processes but also empower organizations to prioritize safety and compliance in their operations.

DF mSafety AI, a cloud-based platform, uses AI/ML and automation for a great user interface and efficiency in Safety Case Management, Neutraceutical, Vaccines and Medical Devices. DF mSafety AI was built on Datafoundry’s Integrated Cloud Platform – DF Safety 4.0, which supports scalable, secure AI/ML-driven Safety Case and Signal Management. It also includes pre-built connectors for enterprise systems and adheres to industry standards and regulatory requirements.

LifeSphere Safety presents a cutting-edge, all-inclusive SaaS Safety platform designed to facilitate seamless case processing, enhance compliance scalability, and standardize pharmacovigilance practices globally. Catalyze significant transformations with top-tier features, incorporating the newest advancements in automation, analytics, and GenAI technologies, all driven by LifeSphere NavaX. Experience remarkable efficiency improvements through touchless case processing, utilizing potent, production-ready automation and AI to optimize routine safety operations. With unmatched turnkey support for both global and regional regulations, confidently navigate any market while benefiting from continuous cloud upgrades that guarantee ongoing compliance. Transform safety into a strategic asset by utilizing powerful, user-friendly resources for reporting, dashboard creation, operational benchmarking, and insightful signal analysis, ensuring your organization remains at the forefront of industry standards. Embrace the future of safety management with LifeSphere Safety's innovative solutions tailored to meet the evolving demands of the regulatory landscape.

Flex Databases is an innovative, unified, and compliant electronic clinical platform that provides software solutions for clinical trials: pharmaceutical companies and CROs. Our system is composed of: - Clinical Trial Management System - Electronic Trial Master File - Project Management & Budgeting solution specifically designed for the clinical trials industry - Pharmacovigilance System - Learning Management System It was possible to create a flexible platform thanks to our unique experience and a qualified team of more than 100 professionals with a deep understanding the clinical trial process.

The K2C PSMF Solution represents an innovative methodology for overseeing the Pharmacovigilance System Master File. Periodic updates to this document are essential whenever there are noteworthy modifications in the pharmacovigilance procedures. Such modifications necessitate collaboration among various roles within the company to edit a document comprised of consistent paragraphs and annexes dictated by regulatory standards. However, coordinating edits can be challenging, especially since certain content must remain exclusive to specific editors and inaccessible to other contributors. The K2C solution addresses this complexity by treating individual paragraphs and annexes as separate documents, facilitating the creation of the final PSMF document through the merging of these various source materials. Additionally, the K2C PSMF Solution encompasses the management of contributions to the PSMF (including both paragraphs and annexes) as distinct entities, the regulation of access rights for both viewing and editing contributions, and comprehensive oversight of the entire document lifecycle, ensuring efficiency and compliance throughout the process. This streamlined approach enhances collaboration while maintaining regulatory adherence.

DF Literature Monitor is a cutting-edge AI-driven tool that streamlines the process of monitoring extensive literature and enhances safety oversight procedures. It connects with key local and global literature sources to retrieve articles simultaneously, utilizing semantic search technology to efficiently pinpoint pertinent research. The system includes features such as automatic de-duplication, the extraction of essential safety information, and the capability to auto-fill safety case forms, which can be easily submitted to safety databases in E2B or Excel/PDF formats with just one click. Furthermore, it provides automated translation services for abstracts and complete articles into English. DF Literature Monitor is equipped with customizable workflows that promote teamwork and ensure quality control within pharmacovigilance teams. By adopting this solution, organizations can significantly reduce the time and resources spent on literature monitoring by as much as 60% or more, all while maintaining high standards of quality and regulatory compliance. Ultimately, the tool represents a significant advancement in the field of pharmacovigilance, allowing teams to focus on critical analysis rather than manual processes.

Oracle Life Sciences Empirica stands out as the premier solution for identifying, analyzing, and managing safety signals that arise from both pre-market and post-market drugs, biologics, vaccines, devices, and combination products. Oracle consistently invests in research and development to enhance the cutting-edge data-mining algorithms and statistical methods utilized in Empirica. This innovative approach allows for the identification of signals significantly earlier, offering risk insights as much as 7 to 22 months in advance of the typical labeling revision timelines based on a time-indexed benchmark. Safety teams engaged in signal management encounter increasing difficulties, including uncovering concealed signals, evaluating data from extensive big data sets, and improving the safety information available before the onset of clinical trials. To explore how emerging methodologies and technologies, such as artificial intelligence, can effectively tackle these evolving challenges, be sure to read our ebook, which provides valuable insights and practical solutions.

PharmaPendium serves as a robust platform that grants users access to a wide array of FDA and EMA drug approval documents, encompassing essential aspects like pharmacokinetics, pharmacodynamics, and safety evaluations. This resource delivers in-depth insights into drug-drug interactions, side effects, and outcomes from clinical studies, thereby empowering stakeholders to make well-informed decisions during the drug development process and when making regulatory submissions. Its rich database aids researchers and healthcare practitioners in assessing both the efficacy and safety of medications, playing a pivotal role in the progression of pharmaceutical research and enhancing patient care. Users can explore historical regulatory submissions and leverage past precedents to better understand and anticipate agency requirements. The interface allows for a seamless transition from tabular data to dynamic charts, graphs, and other visual tools, making it easier to analyze and interpret findings. Additionally, users can search for information related to adverse events (MedDRA), therapeutic targets, drug indications, and endpoints utilizing standardized data. Result pages effectively connect preclinical research with clinical applications, facilitating a comprehensive understanding of the drug development landscape. Overall, this platform not only streamlines the research process but also fosters collaboration and knowledge-sharing among industry professionals.

OpenSourcePV, established by Lionel Van Holle in 2019, aims to leverage free and open-source technologies to enhance pharmacovigilance standards and offer a cost-effective alternative to costly specialized software in this field. Pharmaceutical companies are required to monitor the safety of their products to meet regulatory requirements, but as they expand their product lines and pipelines, the volume of data that needs to be analyzed quickly becomes overwhelming for manual review. Currently, they face a dilemma: invest in an expensive software suite or attempt to develop a solution in-house. OpenSourcePV supports these companies in their journey towards effective quantitative signal detection by providing access to pre-built modules while also enabling customization to fit their unique requirements and data sources. This flexibility allows them to efficiently handle large datasets and improve their overall pharmacovigilance processes.

TrominoCARE is a versatile, cloud-driven Medical Information Call Center (MICC) software crafted to streamline daily operations within medical information call centers. It encompasses a thorough database that facilitates the management of MICC activities throughout their entire lifecycle, addressing different types of calls such as medical queries, product quality issues, and adverse event reports. With accessibility on mobile devices, tablets, and desktops, TrominoCARE promotes adaptability and quick responses across various platforms. Its primary features include automating processes for all call types, generating Field Alert Reports (FARs) automatically, and providing a customizable client product dictionary along with tailored workflows to meet specific business requirements. Additionally, the platform includes a mobile app that empowers medical sales representatives and field teams to collect and report information without needing an internet connection, while also ensuring seamless integration with safety and MICC systems. This comprehensive approach enhances both efficiency and communication within the medical information landscape.

Discover valuable insights within your data by utilizing the Cortellis™ suite of life science intelligence tools, enabling you to make more informed decisions throughout the entire R&D process. We have alleviated the burden of gathering, integrating, and analyzing data, allowing you to concentrate on the essential choices necessary for expediting your products' market entry. With a unique combination of extensive, high-quality data, fortified by profound domain knowledge, industry insight, and therapeutic expertise, Cortellis reveals crucial insights that facilitate data-driven decisions, ultimately speeding up innovation. Access tailored, actionable responses to your specific inquiries throughout the R&D lifecycle, drawing from the most comprehensive and in-depth intelligence sources available. By incorporating Cortellis into your daily routine, you can significantly enhance the pace of innovation and streamline your workflow. This makes Cortellis not just a tool, but a vital partner in your path to success.

Veeva Vault serves as a cloud-based enterprise content management solution designed specifically for the life sciences sector, effectively bridging content gaps within organizations to achieve global uniformity while still allowing for local autonomy. In the past, businesses were often required to use different applications for managing content and separate ones for handling related data. Veeva Vault distinguishes itself as the sole platform capable of integrating both content and data management seamlessly. This integration allows organizations to dismantle silos that exist at the system, site, and country levels, ultimately leading to more efficient workflows spanning commercial, medical, clinical, regulatory, quality, and safety functions. Furthermore, since all Vault applications utilize the same foundational platform, companies benefit from improved efficiency and compliance through a more cohesive document flow across various regions and departments. This ensures that content remains not only accessible but also up-to-date and relevant throughout the entire development and commercial life cycle, enhancing overall operational effectiveness. As a result, Veeva Vault empowers organizations to align their global strategies while still honoring local needs.

Biologit provides an extensive range of software and services aimed at improving safety surveillance in multiple sectors. Their leading offering, biologit MLM-AI, is a comprehensive medical literature monitoring system that utilizes AI technology for both global and local applications. This user-friendly, web-based platform is validated for compliance, resulting in enhanced efficiency for both human and veterinary pharmacovigilance. Notable features encompass integrated search capabilities and customizable literature screening processes, yielding productivity improvements of up to 70% thanks to AI support. Additionally, it presents a flexible and validated SaaS framework that meets GxP standards and adheres to CFR-11 regulations, alongside a database that consolidates significant global and local literature resources while ensuring automatic article de-duplication. Beyond their software offerings, Biologit also provides expert consultancy services related to pharmacovigilance and veterinary pharmacovigilance, further strengthening their commitment to safety in various fields. Their dedication to innovation and compliance positions them as a leader in the industry.

SlimEDC serves as a cloud-based solution for Electronic Data Collection (EDC), enabling the seamless initiation of both retrospective and prospective studies, including patient studies (ePRO) and market research projects, through its user-friendly study editor. Users can choose between a fully managed software option overseen by the research sponsor or a more comprehensive service where a dedicated team from SlimEDC manages the entire process, culminating in data evaluation. Specifically designed to comply with EU regulations and standards, SlimEDC ensures that respondents are engaged electronically while the software automatically generates all necessary reports mandated by regulatory bodies. Additionally, SlimEDC maintains compliance with ISO 9001 and 27001 standards, highlighting its commitment to quality and security. Our team is certified by BHBIA and has completed specialized training in pharmacovigilance to enhance our expertise. Furthermore, strict GDPR audits conducted by independent entities guarantee that our legal and data security measures meet the highest standards, ensuring the protection of sensitive information throughout the research process. By prioritizing both compliance and user experience, SlimEDC positions itself as a reliable partner in the realm of electronic data collection.

Integrated digital asset management tailored for the life sciences sector facilitates worldwide resource sharing and decreases expenditures on marketing materials. Marketing teams have the capability to efficiently publish and retract content across various digital platforms while ensuring that only sanctioned assets are utilized. By leveraging top-tier medical, legal, and regulatory (MLR) processes, organizations can expedite content approval and reduce time to market. An integrated claims library complete with reference links alleviates the administrative load and mitigates risks associated with managing claims across different regions, platforms, and content types. Our industry-specific cloud solutions deliver crucial data, software, services, and a vast network of partners to enhance your essential functions from research and development to commercialization. Veeva empowers businesses, regardless of size, to accelerate their product launches while ensuring compliance and operational efficiency. This comprehensive approach not only streamlines processes but also fosters collaboration among teams, significantly enhancing overall productivity.

The TCS ADD platform significantly enhances the speed at which pharmaceutical companies can bring products to market by streamlining the entire clinical research and development process, ultimately leading to more agile and secure clinical trials. By fostering digital ecosystems and simplifying the intricacies of data management, TCS ADD facilitates quicker access to innovative and effective medications for patients. This platform utilizes the TCS Decision FabricTM, an advanced cognitive artificial intelligence engine, alongside smart analytics and the Internet of Things, delivering exceptional business advantages to the pharmaceutical sector. It serves as a comprehensive, metadata-driven solution designed to uphold industry standards and sponsor requirements in clinical trials. Furthermore, this data science-oriented platform employs artificial intelligence and machine learning technologies to expedite decision-making, accelerate study initiation, and implement targeted interventions. By digitizing the entire supply chain management of clinical trials while prioritizing patient safety, this solution not only improves overall effectiveness but also enhances the patient experience throughout the trial process. Ultimately, TCS ADD represents a transformative approach to clinical trial management that aligns with the evolving needs of healthcare.

Bibliovigilance serves as a dedicated platform for pharmacovigilance literature, designed to enhance the efficiency of monitoring scientific and medical publications for vital safety information. It boasts an extensive database that encompasses notable national scientific publications from Europe and beyond, including those related to both human and veterinary products. Users can conduct comprehensive global searches by utilizing queries in PubMed and can access safety recommendations from the PRAC regarding various signals, thereby centralizing their literature searches in a single interface. The platform allows for the saving of search queries, scheduling of automatic searches, and the option to filter results to only include new articles since the last query, which effectively minimizes redundancy and saves valuable time. Each user’s search history is conveniently stored in a personal area, enabling easy documentation and review at any moment. Furthermore, the database is regularly updated, offering insights into publication dates, the latest updates, and the number of articles indexed, which guarantees clarity and transparency in the information provided. This innovative approach not only aids researchers and professionals in staying informed but also contributes to the overall advancement of pharmacovigilance practices.

Enhance your biomedical research endeavors through the most extensive database of biomedical literature available globally. By utilizing a thorough and contemporary search process, you can access a wealth of biomedical evidence that is both comprehensive and pertinent. Streamline your systematic searches with automated query generation facilitated by user-friendly search forms. Discover critical insights into drug-disease interactions and drug-drug relationships, meticulously curated through extensive indexing efforts. The rapid evolution of biomedical research and development necessitates access to exhaustive information, allowing you to identify potential risks by evaluating all known data. Furthermore, you can monitor safety standards to ensure compliance with regulations while unveiling connections that foster innovation. Embase stands out as a distinctive medical literature database where depth of content exceeds mere quantity. With Emtree indexing of full-text resources and specialized search terminology, you are empowered to locate all significant and up-to-date information, including data that may elude other databases. Scroll down to understand the compelling reasons why regulatory bodies endorse Embase within their best practice recommendations, ensuring that your research is not only thorough but also aligned with industry standards. This commitment to excellence in biomedical literature further positions Embase as an indispensable tool for researchers and practitioners alike.

Scispot delivers a powerful lab informatics platform that transforms how life science labs operate. Through its configurable LabOS™ ecosystem, teams can select from a unified suite of tools covering ELN, LIMS, SDMS, QMS, and AI capabilities—all accessible through an intuitive no-code interface. Purpose-built for CROs, Diagnostic Labs, and Biotech R&D teams, Scispot addresses critical challenges in Sample Management, Freezer Management, and GxP Compliance. The platform seamlessly connects with 200+ lab instruments and 7,000+ applications, eliminating manual data entry while ensuring regulatory adherence. Scispot's AI-powered analytics convert experimental data into actionable insights, accelerating discovery timelines. With rapid implementation and a focus on user experience, Scispot enables 1000+ lab scientists and operators to standardize processes, maintain compliance, and focus resources on innovation rather than administrative overhead.